Related Experiment Video
Updated: Mar 20, 2026

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
Published on: March 12, 2019
Effects of Type 1 Insulin-Like Growth Factor Receptor Silencing in a Human Adrenocortical Cell Line
T C Ribeiro1, A A Jorge1,2, L R Montenegro1
1Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular, LIM/42, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Abstract:
Type 1 insulin-like growth factor receptor (IGF-1R) is overexpressed in a variety of human cancers, including adrenocortical tumors. The aim of the work was to investigate the effects of IGF-1R downregulation in a human adrenocortical cell line by small interfering RNA (siRNA). The human adrenocortical tumor cell line NCI H295R was transfected with 2 specific IGF1R siRNAs (# 1 and # 2) and compared with untreated cells and a negative control siRNA. IGF1R expression was determined by quantitative reverse-transcription PCR (qRTPCR) and Western blot. The effects of IGF-1R downregulation on cell proliferation and apoptosis were assessed. IGF-1R levels were significantly decreased in cells treated with IGF-1R siRNA # 1 or # 2. Relative expression of IGF1R mRNA decreased approximately 50% and Western blot analysis revealed a 30% of reduction in IGF-1R protein. Downregulation of this gene resulted in 40% reduction in cell growth in vitro and 45% increase in apoptosis using siRNA # 2. These findings demonstrate that decreasing IGF-1R mRNA and protein expression in NCI H295R cells can partially inhibit adrenal tumor cell growth in vitro. Targeting IGF1R is a promising therapy for pediatric malignant adrenocortical tumor and can still be an option for adult adrenocortical cancer based on personalized genomic tumor profiling.
Insights
Decreasing insulin-like growth factor 1 receptor (IGF-1R) in adrenocortical tumor cells reduced cell growth and increased apoptosis. This suggests targeting IGF-1R is a promising therapeutic strategy for adrenal cancers.
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- Type 1 insulin-like growth factor receptor (IGF-1R) is frequently overexpressed in various human cancers.
- Adrenocortical tumors, including malignant forms, exhibit IGF-1R overexpression, indicating its potential role in tumorigenesis.
Purpose of the Study:
- To investigate the therapeutic potential of downregulating IGF-1R in human adrenocortical cancer cells.
- To assess the impact of IGF-1R inhibition on cell proliferation and apoptosis in an adrenocortical tumor cell line.
Main Methods:
- Utilized small interfering RNA (siRNA) to specifically target and reduce IGF-1R expression in the NCI H295R human adrenocortical cell line.
- Quantified IGF-1R mRNA levels using quantitative reverse-transcription PCR (qRTPCR) and protein levels via Western blot.
- Evaluated the effects of IGF-1R downregulation on cell proliferation and apoptosis in vitro.
Main Results:
- Transfection with IGF-1R-specific siRNAs significantly decreased both IGF-1R mRNA (approx. 50%) and protein (approx. 30%) levels.
- Downregulation of IGF-1R led to a notable reduction in cell growth (approx. 40%) and a significant increase in apoptosis (approx. 45%) in NCI H295R cells.
- The observed effects were more pronounced with one of the two tested IGF-1R siRNAs (siRNA #2).
Conclusions:
- Reducing IGF-1R expression in adrenocortical tumor cells effectively inhibits tumor cell growth in vitro.
- Targeting IGF-1R represents a promising therapeutic avenue for pediatric malignant adrenocortical tumors.
- IGF-1R inhibition may also be a viable treatment option for adult adrenocortical cancer, particularly when guided by personalized genomic tumor profiling.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Mitogens and the Cell Cycle
Hormones of the Adrenal Glands
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
GPCRs Regulate Adenylyl Cylase Activity
TGF - β Signaling Pathway

